Physician

Patrick John Goleski, M.D.

According to 2025 Medicare claims, Patrick Goleski, M.D. (NPI: 1588989032) practices interventional cardiology in the Bremerton-Silverdale-Port Orchard, WA market, with the plurality of this provider's patient population coming from Kitsap, WA. This provider's primary affiliated billing organization is FRANCISCAN MEDICAL GROUP (NPI: 1366539421; TIN: 911939739) and primary practice location at 98383-7663. Goleski is affiliated with the CommonSpirit ACO I (ACO ID: A2164), Jefferson Accountable Care, LLC (ACO ID: A5275), and PSW ACO (ACO ID: A5323), participating under the MSSP model.

Goleski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,781 traditional Medicare patients, billed 4,115 HCPCS/CPT codes, and received $248,660 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,810 prescription claims across 457 beneficiaries totaling $831,195 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 22 claims. Open Payments data shows 8 records totaling $370. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $6,148 to $831,195. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	359	805	$64,548
2019	1,223	3,363	$255,491
2020	1,490	3,726	$263,591
2021	1,722	4,287	$306,914
2022	1,773	4,303	$276,386
2023	1,746	4,052	$262,296
2024	1,781	4,115	$248,660

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	27	66	$6,148
2016	32	184	$16,303
2017	27	222	$17,973
2018	27	50	$7,532
2019	133	693	$80,566
2020	220	1,340	$164,774
2021	295	1,577	$263,644
2022	306	1,674	$303,478
2023	393	2,103	$538,894
2024	457	2,810	$831,195

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	22	$1,853
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	289	321	$82
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	415	420	$62
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	247	277	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	602	841	$6
93325	Ultrasound of heart with color-depicted blood flow, rate and valve function	194	200	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	150	10,147	$197,432
Entresto	Sacubitril/Valsartan	114	8,650	$187,291
Xarelto	Rivaroxaban	121	8,750	$160,575
Jardiance	Empagliflozin	69	4,650	$81,774
Repatha Sureclick	Evolocumab	73	3,780	$72,704

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$370	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Patrick John Goleski, M.D.?

Tedicare shows public-source Medicare data for Patrick John Goleski, M.D. (NPI 1588989032), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Patrick John Goleski, M.D. have ACO affiliation data?

Patrick John Goleski, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164), Jefferson Accountable Care, LLC (MSSP, ACO ID A5275), and PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Patrick John Goleski, M.D.?

Patrick John Goleski, M.D. is linked to FRANCISCAN MEDICAL GROUP (billing NPI 1366539421) in the available physician profile data.

Does Patrick John Goleski, M.D. have Open Payments data?

Patrick John Goleski, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.